Lorazepam Injection · #12 of 35 active shortages by FDA posting duration
Brand: LORAZEPAM
FDA lists Lorazepam Injection as Active Shortage (Fresenius Kabi USA, LLC).
Availability on file: Available
Lorazepam Injection: Active Shortage
Available 11 shortage presentations are tracked for this drug. Contact your pharmacist if you are affected.
Shortage Details
- Generic Name
- Lorazepam Injection
- Manufacturer
- Fresenius Kabi USA, LLC
- Dosage Form
- Injection
- Presentation
- Lorazepam, Injection, 2 mg/1 mL (NDC 65219-368-02)
- Package NDC
- 65219-368-02
Status & Timeline
- Status
- Active Shortage
- Availability
- Available
- First Reported
- May 3, 2018
- Last Updated
- Mar 17, 2026
- Therapeutic Category
- Neurology
Row fields from the FDA Drug Shortages database via openFDA.
Shortage Reason
Check wholesalers for inventory
Full Drug Profile
lorazepam
Side effects, interactions, warnings & more
Nearby, Other Lorazepam Shortage Records
Lorazepam Injection
Hospira, Inc., a Pfizer Company
Injection
Lorazepam Injection
Hikma Pharmaceuticals USA, Inc.
Injection
Lorazepam Injection
Hikma Pharmaceuticals USA, Inc.
Injection
Lorazepam Injection
Hikma Pharmaceuticals USA, Inc.
Injection
Lorazepam Injection
Hikma Pharmaceuticals USA, Inc.
Injection
Lorazepam Injection
Hikma Pharmaceuticals USA, Inc.
Injection
FDA reason on file: Check wholesalers for inventory. General shortage guidance lives on the tracker hub.